This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar

Astex Pharmaceuticals

Another under-$10 name that looks ready to break out here is drug developer Astex Pharmaceuticals (ASTX - Get Report), which engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. This stock is off to a decent start in 2012, with shares up around 12%.

If you take a look at the chart for Astex Pharmaceuticals, you'll notice that this stock recently formed a double bottom chart pattern at around $1.57 to $1.58 a share in May. After making that bottom, shares of Astex Pharmaceuticals have started to uptrend strong, with shares mostly making higher lows ad higher highs, which is bullish technical price action. That move has pushed ASTX within range of triggering a major breakout trade.

>>5 Health Care Stocks Setting Up to Break Out

Traders should now look for long-biased trades in ASTX if it can manage to trigger a break out trade above some near-term overhead resistance at $2.17 a share, and then above some past resistance at $2.20 a share with high-volume. Look for a sustained move or close above those levels on volume that's near or above its three-month average action of 380,606 shares. If we get that action soon, then ASTX could have some major upside towards $2.95 a share, or possibly higher. That move will likely happen if ASTX moves into its previous gap-down above $2.60 a share.

One could be a buyer of ASTX off weakness to anticipate the breakout, and simply use a stop right below some major near-term support at $2 a share. You could even put the stock right below its 50-day moving average of $1.82 a share if you want to give it more room. One could also just buy off strength and get long above $2.17 to $2.20 once those levels are taken out with high-volume. I would simply use a stop a few percentage points below those levels if you get long off strength.

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ASTX $0.00 0.00%
DATE $6.12 0.49%
MCHX $4.87 -2.40%
SKYW $14.86 -3.13%
SBSA $6.18 -3.10%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs